Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.

Saved in:
Bibliographic Details
Main Authors: Lalit Saini, Jack T Seki, Deepali Kumar, Eshetu G Atenafu, David EC Cole, Betty YL Wong, Andrea Božović, Joseph M Brandwein
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2014/214813
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553752746262528
author Lalit Saini
Jack T Seki
Deepali Kumar
Eshetu G Atenafu
David EC Cole
Betty YL Wong
Andrea Božović
Joseph M Brandwein
author_facet Lalit Saini
Jack T Seki
Deepali Kumar
Eshetu G Atenafu
David EC Cole
Betty YL Wong
Andrea Božović
Joseph M Brandwein
author_sort Lalit Saini
collection DOAJ
description INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.
format Article
id doaj-art-6c379212e1fc49e4aa8c3acb7be885d9
institution Kabale University
issn 1712-9532
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-6c379212e1fc49e4aa8c3acb7be885d92025-02-03T05:53:16ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-0125527127610.1155/2014/214813Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole TherapyLalit Saini0Jack T Seki1Deepali Kumar2Eshetu G Atenafu3David EC Cole4Betty YL Wong5Andrea Božović6Joseph M Brandwein7Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacy, Princess Margaret Cancer Centre, CanadaTransplant Infectious Diseases, Alberta Transplant Institute, CanadaBiostatistics Department, Princess Margaret Cancer Centre, CanadaDepartment of Laboratory Medicine and Pathophysiology and Department of Clinical Pathology, University of Toronto, CanadaDepartment of Clinical Pathology, Sunnybrook Health Sciences Centre, CanadaLaboratory Medicine Program, Toronto General Hospital, University Health Network, CanadaDivision of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaINTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.http://dx.doi.org/10.1155/2014/214813
spellingShingle Lalit Saini
Jack T Seki
Deepali Kumar
Eshetu G Atenafu
David EC Cole
Betty YL Wong
Andrea Božović
Joseph M Brandwein
Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
Canadian Journal of Infectious Diseases and Medical Microbiology
title Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
title_full Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
title_fullStr Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
title_full_unstemmed Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
title_short Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
title_sort serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
url http://dx.doi.org/10.1155/2014/214813
work_keys_str_mv AT lalitsaini serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT jacktseki serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT deepalikumar serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT eshetugatenafu serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT davideccole serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT bettyylwong serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT andreabozovic serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy
AT josephmbrandwein serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy